Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Durvalumab

연구 개요

The rationale of the ROSY-D study is to continue to provide study treatment for patients who have participated in a parent study with Durvalumab and who are continuing to derive clinical benefit from treatment at the end of such studies, as judged by the Investigator.